Hypercalcaemia in head and neck squamous cell carcinoma

Current Opinion in Otolaryngology and Head and Neck Surgery

Volumn 14, Issue 2, 2006, Pages 51-54

  Bradley, Patrick J ^a   Hoskin, David ^b  

^a QUEEN S MEDICAL CENTRE   (United Kingdom)

^b NOTTINGHAM CITY HOSPITAL   (United Kingdom)

Author keywords

Head and neck cancer; Hypercalcaemia; Parathyroid hormone

Indexed keywords

ALKALINE PHOSPHATASE; BISPHOSPHONIC ACID DERIVATIVE; CALCITONIN; CALCIUM; CREATININE; ELECTROLYTE; PAMIDRONIC ACID; PARATHYROID HORMONE; PARATHYROID HORMONE RECEPTOR; PARATHYROID HORMONE RELATED PROTEIN; PHOSPHATE; SERUM ALBUMIN; SULFONIC ACID DERIVATIVE; TRANSFORMING GROWTH FACTOR BETA; UREA; VASOPRESSIN; ZOLEDRONIC ACID; ALPHA2 INTERFERON; ANTINEOPLASTIC AGENT; DACARBAZINE; NITROSOUREA DERIVATIVE; PLATINUM DERIVATIVE; TAMOXIFEN;

ADVANCED CANCER; BONE METASTASIS; CALCIUM BLOOD LEVEL; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER RADIOTHERAPY; COMA; CONSTIPATION; DIZZINESS; ERYTHROCYTE SEDIMENTATION RATE; ESOPHAGUS CARCINOMA; FATIGUE; HEAD AND NECK CARCINOMA; HUMAN; HYPERCALCEMIA; HYPOPHARYNX CARCINOMA; KIDNEY CALCIFICATION; LARYNX CARCINOMA; LETHARGY; LIVER FUNCTION TEST; LUNG CARCINOMA; MOUTH CARCINOMA; NAUSEA; NEPHROGENIC DIABETES INSIPIDUS; NEPHROLITHIASIS; OROPHARYNX CARCINOMA; OSTEOLYSIS; PARATHYROID HORMONE BLOOD LEVEL; PHOSPHATE BLOOD LEVEL; POLYDIPSIA; POLYURIA; PRIMARY HYPERPARATHYROIDISM; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; REHYDRATION; REVIEW; SOMNOLENCE; SQUAMOUS CELL CARCINOMA; SYMPTOMATOLOGY; SYSTEMATIC REVIEW; VOMITING; CANCER CONTROL; CANCER IMMUNOTHERAPY; CANCER STAGING; CANCER SURVIVAL; FOLLOW UP; HEAD AND NECK CANCER; MELANOMA; METASTASIS; POSTOPERATIVE CARE; RARE DISEASE; SALVAGE THERAPY; TREATMENT INDICATION; TREATMENT OUTCOME; ANAMNESIS; FLUID THERAPY; HEAD AND NECK TUMOR;

COMBINED MODALITY THERAPY; HEAD AND NECK NEOPLASMS; HUMANS; MELANOMA; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; CALCITONIN; CARCINOMA, SQUAMOUS CELL; DIPHOSPHONATES; FLUID THERAPY; HYPERCALCEMIA; MEDICAL HISTORY TAKING;

EID: 33646071595     PISSN: 10689508     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.moo.0000193176.54450.c4     Document Type: Review

References (18)

1. Conroy S, O'Malley B. Hypercalcaemia in cancer. BMJ 2005; 331:954. A short article that highlights that hypercalcaemia, if diagnosed in cancer patients, may not always be associated with the cancer.
2. Nussbaum SR, Zahradnik RJ, Lavigne JR, et al. Highly sensitive two-site immunoradiometric assay of parathyrin and its clinical utility in evaluating patients with hypercalcaemia. Clin Chem 1987; 3:1364-1367 (1987).
3. Dorman EB, Yang G, Vaughan CW, et al. The incidence of hypercalcaemia in squamous cell carcinoma of the head and neck. Head Neck Surg 1984; 7:95-98.
4. Won C, Decker DA, Drelichman A, et al. Hypercalcaemia in head and neck carcinoma, incidence and prognosis. Cancer 1983; 52:2261-2263.
5. Rikimaru K, Matsumoto F, Hayashi E, et al. Elevation of serum concentration of parathyroid hormone-related protein and its implication in hypercalcaemia in squamous cell carcinoma of the head and neck. Int J Oral Maxillofac Surg 1995; 24:365-368.
6. Aryian S, Faber LR, Hamilton BP, et al. Pseudo-hyperparathyroidism in head and neck tumours. Cancer 1974; 33:159-166.
7. Broadus AE, Mangin MM, Ikeda K, et al. Humoral hypercalcaemia in cancer. Identification of a novel parathyroid hormone-like peptide. N Engl J Med 1988; 319:556-563.
8. Stephens RL, Hansen HH, Muggia FM. Hypercalcaemia in Epidermoid tumours of the head and neck and oesophagus. Cancer 1973; 31:1487-1491.
9. Sellers RS, Schuller DE, Sharma PK, et al. Head and neck squamous cell carcinoma; Measurement of plasma parathyroid hormone-related protein and serum and urine calcium concentrations. Otolaryngol Head Neck Surg 2000; 123:558-562.
10. Gavrila A, Hasinski S, Rose LL. Hypercalcaemia associated with squamous cell carcinoma of the tongue. Endocr Pract 2001; 7:459-462.
11. Fujikawa M, Takata Y, Akamura K, et al. Hypercalcaemia associated with parathyroid hormone-related protein at the terminal stage of uncomplicated squamous cell carcinoma in the head and neck region. Head Neck 2002; 24:56-62.
12. Iwase M, Kurachi Y, Katuta S, et al. Nagumo, M. Hypercalcaemia in patients with oral squamous cell carcinoma. Clin Oral Investig 2001; 5:194-198.
13. Yoneda T, Nishikawa N, Nishimura R, et al. Three cases of oral squamous cell cancer associated with leukocytosis, hypercalcaemia, or both. Oral Surg Oral Med Oral Pathol 1989; 68:604-611.
14. Gover A, Kumar PD, Brown LA, Ravakhah K. Hypercalcaemia induced by parathyroid hormone-related peptide after treatment of carcinoma. South Med J 2002; 95:258-260.
15. Penel N, Berthon C, Everard F, et al. Prognosis of hypercalcaemia in aerodigestive tract cancers: study of 136 recent cases. Oral Oncol 2005; 41:884-889. This is the most recent article published that reviews the clinical presentation and outcomes of patients with hypercalcaemia.
16. Brawner JT, Zitsch RP. Parathyroid hormone-related peptide as a cause of hypercalcaemia in squamous cell carcinoma of the head and neck: a case presentation and subject review. Head Neck 2004; 26:382-384.
17. Degardin M, Ngyuyen M, Beaurin D, et al. Hypercalcaemia and squamous cell carcinoma of the upper respiratory-digestive tracts. Incidence and prognosis. Bull Cancer 1995; 82:975-980.
18. Pecherstorfer M, Brenner K, Zojer N. Current management strategies for hypercalcaemia. Treat Endocrinol 2003; 2:273-292.